Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 323 of 6351
-
Experimental vaccine aims to train body to attack breast cancer
Vaccine Recruiting nowThe goal of this study is to test an investigational vaccine to activate the immune system to fight breast cancer.
Phase 1 • Sponsor: Pravin T.P Kaumaya • Aim: Vaccine
Last updated Aug 29, 2026 00:00 UTC
-
Colombia launches first CAR-T trial for Hard-to-Treat blood cancers
Disease control Not yet recruitingThis is a hybrid type two study, with two simultaneous development phases. Phase A involves developing a public-private partnership to create the conditions for implementing CAR-T cell therapies in Colombia. Phase B will be a single-arm, non-randomized pilot clinical trial in pat…
Sponsor: GUSTAVO SALGUERO • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New blood test could spot pancreatic cancer earlier
Diagnosis Not yet recruitingThe purpose of this research study is to test a new process for diagnosing pancreatic cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this st…
Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
New hope for aggressive prostate cancer: carboplatin combo tested in phase 3 trial
Disease control Not yet recruitingThe current standard of patients with de novo metastatic hormone sensitive prostate cancer (mHSPC) is to offer androgen deprivation therapy (ADT) with androgen receptor pathway inhibitors (ARPI). In addition, upfront 6 cycles of docetaxel, if patient is eligible, and prostate rad…
Phase 3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Glow-in-the-dark dye may help surgeons spot hidden prostate cancer cells
Diagnosis Not yet recruitingThis study is being done to support the selection of single dose and timing regimen of Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent imaging to improve the detection of malignant (growing in an uncontrolled way) tissue in adult patients undergoing prosta…
Phase 2/3 • Sponsor: Clinton Bahler • Aim: Diagnosis
Last updated Aug 01, 2026 00:00 UTC
-
The diet paradox: could eating more actually help you keep weight off?
Knowledge-focused Not yet recruitingWeight loss is difficult and weight maintenance even worse. The principles of dieting dictate that to maintain weight loss, one has to eat less calories than they did before the diet. However, there is evidence to show that it may be the diet per se and not the weight loss that m…
Sponsor: University of Ottawa • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
A new program aims to help teens thrive when a parent faces cancer
Symptom relief Not yet recruitinge purpose of this study is to develop and evaluate SHINE (Support and Healing Intervention for Navigating Parental Cancer Experiences), a family-centered program designed to support adolescents whose parent has been diagnosed with cancer. The study has two phases. In the first p…
Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can a digital parenting program empower latino families?
Prevention Not yet recruitingThe objective of this study is to harness digital technology to bring to scale a culturally adapted and evidence-based parenting intervention for Latinos (Nuestras Familias: Andando Entre Culturas). The Latino Youth and Family Empowerment - III study (LYFE-III) proposed here will…
Sponsor: Texas A&M University • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC
-
Can a Two-Drug combo keep aggressive lymphoma at bay?
Disease control Not yet recruitingThis is a prospective, single-arm, single-center clinical study evaluating pomalidomide combined with rituximab as maintenance treatment in young high-risk patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) who have achieved at least a partial response after firs…
Phase 4 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new infusion stop the Body's attack on a transplanted kidney?
Disease control Not yet recruitingTo evaluate the safety and tolerability of SG301 injection in patients with antibody-mediated rejection (AMR) after renal transplantation.
Phase 2 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a tailored rehab boost recovery after pancreatic surgery?
Symptom relief Not yet recruitingThe REACT study is a prospective, single-center, single-cohort study designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection (pancreatoduodenectomy …
Sponsor: IRCCS San Raffaele • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Can a common supplement heal diabetic foot ulcers faster?
Disease control Recruiting nowPrimary outcome: To evaluate the efficacy of L-Carnitine supplementation on length and depth ulcer size Secondary outcome: To investigate the effect of L-Carnitine supplements on: 1. Vascular endothelial growth factor (VEGF) 2. Inflammatory markers TNF-a (Tumor necrosis factor …
Phase 2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could popular Weight-Loss drugs also fight gum disease?
Disease control Not yet recruitingThis study aims to evaluate the effects of glucagon-like peptide-1 receptor agonist (GLP-1 RA) use on periodontal health and the response to non-surgical periodontal therapy in individuals with obesity and periodontitis. Participants with obesity and periodontitis will be divide…
Sponsor: Cukurova University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
A rapid test to solve the TB lymph node puzzle
Diagnosis Not yet recruitingThis prospective, multi-center study aims to evaluate the Molecular Bacterial Load Assay (MBLA) on lymph node aspirates as a tool to distinguish between late immune reconstitution inflammatory syndrome (IRIS) and treatment failure in patients with extrapulmonary tuberculosis (TB)…
Sponsor: Research Center Borstel • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
Can a natural compound block Alzheimer's brain damage?
Disease control Not yet recruitingInvestigators propose a phase 1b/2a, randomized, double-blind, placebo-controlled, parallel group dose finding and biomarker study to evaluate the safety, tolerability, and biomarker activity of 2-HOBA in 48 MCI/AD participants. Participants will be randomized 1:1:1:1 to receive …
Phase 1/2 • Sponsor: MTI Biotech Inc • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a new injection quiet severe eczema?
Disease control Not yet recruitingThis is a Phase I/II, multicenter, randomized, double-blind, placebo-controlled study evaluating HXN6005 in healthy participants and patients with moderate-to-severe atopic dermatitis (AD). The study consists of three parts: Part A (single ascending dose in healthy participants)…
Phase 1/2 • Sponsor: Helixon Biotechnology (Suzhou) Co., Ltd • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
A simpler pill regimen takes on h. pylori — could it dethrone the standard cure?
Disease control Not yet recruitingMost international treatment guidelines currently recommend a 14-day bismuth quadruple therapy as the first-line treatment for Helicobacter pylori infection, especially in areas with high clarithromycin resistance. While this therapy boasts good eradication rates, its administrat…
Sponsor: Chih-An Shih, MD • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can talk therapy help men at HIV risk embrace PrEP?
Prevention Not yet recruitingThe purpose of this research study is to adapt, implement, and evaluate a 10-session mental health intervention with men who have sex with men at the Regional AIDS Interfaith Network to find out if it will reduce anxiety and depression and increase awareness and use of pre-exposu…
Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Aug 30, 2026 00:00 UTC
-
Can a Two-Drug cream clear precancerous skin spots even when immunity is suppressed?
Disease control Not yet recruitingCombination field therapy with 5-fluorouracil and calcipotriene (5FU/C) has become standard of care among dermatologists for the field treatment of diffuse actinic keratoses (AKs). Data suggest that the addition of calcipotriene elicits a sustained T cell memory allowing for both…
Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can skipping opioids during anesthesia prevent Post-Surgery nausea?
Symptom relief Not yet recruitingThe invistigators hypothesized that a protocolized OFA technique would lower the occurance of PONV in patients undergoing thoracoscopic lung surgery compared to standard opioid-based anaesthesia.
Sponsor: Sohag University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC